17
Hoffmann & Krueger Copyright 2013 Hoffmann Krueger Consulting Ltd., c/o SFM Rue Adrien-Lachenal 20 1207 Geneva, Switzerland Hoffmann Krueger Consulting Ltd., P.O. Box 33582, Ras Al Khaimah, United Arab Emirates

Hoffmann &Krueger Oncology Excellence

Embed Size (px)

DESCRIPTION

Hoffmann & Krueger Consulting is a specialized and independent oncology data provider. We make the connections between scientific innovations, medical cancer needs and market opportunities. We are delivering strategic perspectives and market insight solutions that proactively address challenges and opportunities for oncology portfolio and cancer pipeline products. We have built a strong international reputation for covering oncology and pharmaceuticals healthcare critical topics and investigating issues that other information providers are not able to do

Citation preview

Page 1: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Hoffmann Krueger Consulting Ltd., c/o SFM

Rue Adrien-Lachenal 20

1207 Geneva, Switzerland

Hoffmann Krueger Consulting Ltd., P.O. Box 33582, Ras Al Khaimah, United Arab Emirates

Page 2: Hoffmann &Krueger Oncology Excellence

1

Page 3: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013 2

Page 4: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

R E A C T ethink valuate ccelerate hange ransform The patient Connection

Your current Tactics

The Growth Your Model Your Strategy

R E A C T

3

Page 5: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Ability to deliver

value-added data,

analysis, report,

advices in oncology

4

Page 6: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Oncology

strategies

R&D

Market Access

Life Cycle

Management

Patent

Generics

Biosimilars Companies

sizes

Big pharma

Spin-off

Start-up

Biosimilars

Generics

Epidemiology Oncology

product

Forecast

New product

Launch

Pricing

Treatment

algorithms

Patients cohorts

Genetic type

5

Page 7: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Hoffmann & Krueger

6

Page 8: Hoffmann &Krueger Oncology Excellence

7

Page 9: Hoffmann &Krueger Oncology Excellence

8

Page 10: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

9

Page 11: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

References to FR and ITA (key countries), UK, GER, but also to smaller price-controlled countries like BE or AUT if it helps payers

Past practice: parity to lowest available EU reference price or minus ~5% to 10% References mainly FR and SP (key countries), but

also UK, GER, and western Europe countries

Unlikely to accept prices higher than in EU-4 (FR, GER, SP, UK)

AIFA may ask for a report of any price changes in other EU countries.

No influence from other countries

No influence from other countries

ASMR IV-V: No formal EU price referencing; national price

benchmarks decisive, but lowest EU-4 price can serve as a price

cap if it is below the reference of the national comparator chosen.

Sample of analysis made for our client : “Impact of referencing in oncology European prices”

10

Page 12: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Hoffmann Krueger Consulting Ltd., c/o SFM

Rue Adrien-Lachenal 20 1207 Geneva, Switzerland

[email protected]

11

Page 13: Hoffmann &Krueger Oncology Excellence

12

Page 14: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

http://www.rki.de/

The Robert Koch Institute collaborates with the German

Association of Population-Based Cancer Registries to publish

national cancer statistics for Germany. The coverage of

Germany by the registries is nearly 100% complete. This data

represents the most robust and complete data source available

for Germany.

http://www.iarc.fr/index.html

IARC is studying cancer incidence, mortality, and survival in

numerous countries and is thus playing a leading role in cancer

registration worldwide. IARC's founding members were Germany,

France, Italy, the United Kingdom, and the United States, IARC's

membership has grown to 20 countries (founding states plus

Australia, Belgium, Canada, Denmark, Finland, India, Ireland,

Japan, Norway, the Netherlands, Republic of Korea, Russian

Federation, Spain, Sweden, and Switzerland).

http://www.ecosante.fr/DEPAFRA/3034.html

FRANCIM is a network of cancer registries in France

http://www.eurocare.it/

EUROCARE project (European cancer registries study on

cancer patients' survival and care) is an international

collaborative study on the survival of cancer patients in

Europe. It currently involves 67 population-based cancer

registries operating in 22 European countries,

13

Page 15: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Journal of medical oncology

International Journal of Cancer

British Journal of Cancer

Journal of Thoracic Oncology

European Journal of Cancer

Oncogene

Clinical Cancer Research

New England Journal of Medecine

14

Page 16: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

1.Role of Hoffmann& Krueger Consulting Ltd.

Hoffmann&Krueger Consulting Limited will carry out the services set out in the Engagement proposal and will not be obliged to provide any other advice or services unless it expressly agrees to do so. Any advice rendered by Hoffmann&Krueger Consulting Ltd, unless otherwise agreed by us, is solely for the benefit of the Client and must be kept confidential. This advice may not be relied on by the Client other than for the purposes of the Engagement and may not be disclosed to any third party or announced publicly unless there is a legal or regulatory obligation to disclose or announce it or otherwise agreed by Hoffmann&Krueger Consulting Ltd. Such advice may not be used or relied on by any third party without Hoffmann&Krueger Consulting Ltd's prior written consent. 2. Authority and Information

Hoffmann&Krueger Consulting Ltd is entitled to assume that its instructions in relation to the Engagement have been properly authorised by the Client if they are given by a director or senior executive of the Client or by any of the persons referred to in the proposal. Hoffmann&Krueger Consulting Ltd is authorised by the Client to carry out such steps as it considers necessary to complete the Engagement including acting through agents. The Client understands and agrees that Hoffmann&Krueger Consulting Ltd in performing its Engagement, will use and rely upon information provided by the Client as well as publicly available information and that Hoffmann&Krueger Consulting Ltd does not assume responsibility for independent verification of any information, whether publicly available or otherwise furnished to it by the Client. Accordingly, Hoffmann&Krueger Consulting Ltd shall be entitled to assume and rely upon the accuracy, fairness and completeness of all such information. All reports and data is the property of the client but all documents, questionnaires, cards etc. on which the data is recorded shall be the property of the Company. Copies of any or all of this material in an anonymous form can be made available to clients on request on payment of additional fees. If wider circulation of results is intended, Hoffmann&Krueger Consulting Ltd name may not be quoted in connection with the study until the exact form of any communication has been agreed by Hoffmann&Krueger Consulting Ltd. The Client undertakes to inform Hoffmann&Krueger Consulting Ltd of any intended wider publication prior to release and to offer identification of Hoffmann&Krueger Consulting Ltd as the supplier of the work to be published.

3. Disclosure of Interests

It is possible that Hoffmann&Krueger Consulting Ltd and/or one of its associates and/or one of

Their respective officers, employees, representatives or agents or another client of the

Hoffmann&Krueger Consulting Ltd may have interests, relationships and/or arrangements that

give rise to conflicts or interests which are otherwise material in relation to the Engagement

("Other Interests"). So far as Hoffmann&Krueger Consulting Ltd is aware without having made

enquiry of any of its clients, no other client of Hoffmann&Krueger Consulting Ltd has, as at the

date of the project agreement, any Other Interests and Hoffmann&Krueger Consulting Ltd agrees

to notify the Client if it becomes aware during the Engagement of any of its clients having any

Other Interests provided that Hoffmann&Krueger Consulting Ltd shall not be required to disclose

details of the names of any such clients or any other details concerning such clients to the Client

pursuant to this Clause 3

The employees of the Hoffmann&Krueger Consulting Ltd assigned to the Engagement may be

unaware of, and in any event are required to disregard, any Other Interests and the Client agrees

that Hoffmann&Krueger Consulting Ltd may act for it despite Other Interests and that any profit

or remuneration from such interests may be retained by Hoffmann&Krueger Ltd.

The Client agrees that Hoffmann&Krueger Consulting Ltd does not have a duty to disclose any

matter which comes to its notice in the course of their business if doing so would constitute a

breach of duty owed to other persons.

Hoffmann&Krueger Consulting Ltd will remain bound by any Confidentiality Agreement entered

into between the parties.

15

Page 17: Hoffmann &Krueger Oncology Excellence

Hoffmann & Krueger Copyright 2013

Hoffmann Krueger Consulting Ltd., c/o SFM

Rue Adrien-Lachenal 20

1207 Geneva, Switzerland

Hoffmann Krueger Consulting Ltd., P.O. Box 33582, Ras Al Khaimah, United Arab Emirates